Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-19T01:55:27.283Z Has data issue: false hasContentIssue false
  • English
  • Français

Tardive dyskinesia: risk disclosure and informed consent in the Netherlands

Published online by Cambridge University Press:  02 January 2018

Walter Pierre Bouman  and
Jon Arcelus-Alonso
Walter Pierre Bouman
Affiliation:
Department of Health Care of the Elderly, University Hospital, Nottingham NG7 2UH
Jon Arcelus-Alonso
Affiliation:
Northern General Hospital, Sheffield S5 7AU
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
Psychiatric Bulletin , Volume 21 , Issue 5 , May 1997 , pp. 302
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

American Psychiatric Association (1992) Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Press.Google Scholar
Brabbins, C., Butler, J. & Bentall, R. (1996) Consent to neuroleptic medication for schizophrenia: clinical. ethical and legal issues. British Journal of Psychiatry, 168, 540–544.Google Scholar
Rogers, A., Pilgrim, D. & Lacey, R. (1993) Experiencing Psychiatry: Users' Views of Services. London: Macmillan/MIND Publications.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.